Home › Funds › CADEN CAPITAL PARTNERS, LP › HUM

CADEN CAPITAL PARTNERS, LP position in HUM

HUMANA INC · Health Care

CADEN CAPITAL PARTNERS, LP reported holding 641 shares of HUM (HUMANA INC) in its Q2 2026 13F filing — a position valued at US$255K, representing 3.07% of its reported portfolio and ranking #10 among its reported holdings. CADEN CAPITAL PARTNERS, LP has disclosed HUM holdings in 7 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)641 sh
Reported value held$254.62K
Portfolio Weight3.07%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CADEN CAPITAL PARTNERS, LP's HUM position evolved

CADEN CAPITAL PARTNERS, LP first disclosed a stake in HUM in Q4 2023 at 26,718 shares (US$12.2M). The position peaked in Q3 2024 at 108,524 shares, worth US$34.4M. Across 7 filings, CADEN CAPITAL PARTNERS, LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 641 shares valued at US$255K — a reduction of -750 shares quarter over quarter.. Notable position changes include a 59% increase in Q1 2024 (shares rose 8% over the following quarter), a 196% increase in Q3 2024 (shares fell 20% over the following quarter), a 218% increase in Q1 2026 (shares rose 130% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 26.72K $12.23M New
Q1 2024 42.49K $14.73M Add
Q2 2024 36.68K $13.71M Reduce
Q3 2024 108.52K $34.37M Add
Q4 2025 437 $111.93K New
Q1 2026 1.39K $241.19K Add
Q2 2026 641 $254.62K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HUM and 13F data

HUM (HUMANA INC) is a Health Care company. 33 other funds we track also report a position in HUM — the largest reported positions include Dodge & Cox (US$4.35B), DODGE & COX (US$4.35B), Pzena Investment Management (US$1.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HUM

All HUM fund holders →

FAQ

How long has CADEN CAPITAL PARTNERS, LP held HUM?

CADEN CAPITAL PARTNERS, LP has disclosed HUM holdings in 7 of the last 11 reported quarters, going back to Q4 2023.

What is CADEN CAPITAL PARTNERS, LP's current position in HUM?

As of Q2 2026, CADEN CAPITAL PARTNERS, LP holds 641 shares of HUM (HUMANA INC), valued at $254.62K, representing 3.07% of its reported portfolio and ranking #10.

Has CADEN CAPITAL PARTNERS, LP been buying or selling HUM?

In the latest 13F filing (Q2 2026), CADEN CAPITAL PARTNERS, LP reduced its position in HUM. The position peaked in Q3 2024 at 108.52K shares.

Which other funds hold HUM?

Other major institutional holders of HUM include Dodge & Cox, DODGE & COX, Pzena Investment Management, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.